The case is reported of a 50 year old man with longstanding seronegative rheumatoid arthritis who developed ulcerative colitis. The patient also had sacroiliitis and his tissue was typed as HLA-A2-B27 several years before the bowel disease began. A possible overlap between primary inflammatory bowel disease, complications to the treatment of rheumatoid arthritis with drugs, and gastrointestinal rheumatoid vasculitis is discussed.
Intestinal inflammation and ulceration are recognised complications to the treatment of rheumatoid arthritis (RA) with drugs.`-In addition, a specific form of peripheral arthritis and sacroiliitis affects as many as 15 NSAIDs have an additional part to play. Small intestinal ulcerations and overgrowth of caecal type microorganisms have been observed in rats treated with NSAIDs. " Two thirds of patients with RA receiving long term treatment with NSAIDs had small intestinal inflammation as shown by indium-leucocyte scans, increased small bowel permeability, and abnormal scans of the colon performed with the chromium-EDTA absorption test.'5 Our patient continuously received various kinds of NSAIDs. This might increase gut permeability and decrease mucosal prostaglandin synthesis, allowing access to microorganisms and toxins. A cross reactivity between HLA-B27 and yersinia and klebsiella species has been described.'6 This patient also had increased levels of circulating immunoglobulins. Thus a damaged gut mucosa during treatment with penicillamine and NSAIDs, cross reactivity between HLA types and microorganisms, and increased levels of circulating immunoglobulins with the formation of local immune complexes could all function together to yield bowel inflammation.
It is also possible that the inflammatory bowel disease of our patient merely represented a true extension of rheumatoid vasculitis to the bowels. A study of 59 unselected patients with RA without gastrointestinal symptoms showed vasculitic lesions in 4-3% of gastric, 15-7% of colonic, and 30 5% of rectal biopsy samples. Based on this patient, we suggest the existence of a subset of seronegative patients with RA with the HLA-A2-B27 antigen and sacroiliitis. These patients represent an overlap between primary inflammatory bowel disease, bowel disease complicating the treatment of RA with drugs, and true extension of rheumatoid vasculitis to the gastrointestinal tract.
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